南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

PCMTD1-127aa竞争性结合USP10促进c-MYC降解抑制骨肉瘤进展

PCMTD1-127aa suppresses osteosarcoma progression by competitively binding to USP10 to promote c-MYC degradation

Anan Li, Shijiang Wang, Fan Li, Xu Xiong, Ning Liu, Xinsheng Xie, Geliang Yao, Zhili Liu, Meiying Yan, Feng Yang

Journal:iScience

IF:4.5

DOI:10.1016/j.isci.2026.114765

PMID:41732254

Published:2026-01-29

research field:分子生物学药理学细胞生物学天然产物衰老研究生物化学

Abstract

Osteosarcoma (OS) is a highly malignant tumor prone to distant metastasis and is associated with a poor prognosis. To date, therapeutic outcomes for this disease remain unsatisfactory. In this study, we found that circPCMTD1 encodes a 127-amino acid protein, termed PCMTD1-127aa in OS. The expression of PCMTD1-127aa was significantly lower in OS tissues than in normal paratumoral tissues. Clinical data analysis revealed that low expression of PCMTD1-127aa was associated with poor OS prognosis. Functionally, overexpression of PCMTD1-127aa not only inhibited the proliferation and invasion of osteosarcoma cells but also suppressed glycolysis in these cells. Mechanistically, PCMTD1-127aa competitively bound to the F1 (1–100) domain of USP10, thereby counteracting the USP10-mediated deubiquitination of c-MYC and subsequently promoting c-MYC degradation. We further identified that amino acid 148 of c-MYC plays a critical role in ubiquitination-mediated degradation. Our findings reveal the PCMTD1-127aa/USP10/c-MYC axis may be a promising therapeutic target for OS. Biological sciences; Cancer

本文使用的Yeasen产品

购物车
客服
转染试用